Free CME/CE
Incentive provided
The University of Florida and The Leukemia & Lymphoma Society are seeking participants for a compensated research study where primary care providers engage in a free, online, self-guided training designed to enhance the important work you do to prepare your patients for cancer treatment discussions, including raising their awareness of clinical trials as a treatment option (University of Florida, ET00021321).
To help us assess this interactive training, you will be asked to complete brief surveys before and after the program. You are eligible to participate in this research if you meet all of the following requirements:
- You are a physician, physician assistant, or nurse practitioner currently providing primary care in an outpatient setting
- You have made patient referrals to specialists for cancer treatment in the last year
- You are an English speaker and reside in the U.S. or its territories
To compensate you for your time and participation, eligible participants who complete the pre- and post-training surveys (approximately 15 minutes total) and the interactive training (approximately 1 hour total) will be sent a $150 gift card. An additional $20 gift card will be sent upon completion of the 3-month post survey, and an additional $25 gift card will be sent upon completion of the 6-month post survey (approximately 10 minutes total).
CME for Physicians and Physician Associates/Physician Assistants
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Florida College of Medicine and The Leukemia & Lymphoma Society. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Florida College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the online training.
CE for Nurses
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.
There are no fees for participating in or receiving credit for this CE activity. To be eligible to earn CE credit, you must complete the entire course, including the post-test and evaluation. Once you have completed the course, a certificate of completion will be emailed to you.
To participate, please contact study coordinator, Alyssa Crowe at alyssacrowe@ufl.edu
Why does this course matter?
“A key aspect to advancing health equity and ensuring access to high quality health care for all is by achieving increased diversity in clinical trials.”
— Nicholas, S.B, et al (2022). Health Care Equity and Justice Scorecard To Increase Diversity in Clinical Trial Recruitment and Retention. Journal of the American Society of Nephrology: JASN, 33(9), 1652-1655.
“Adequate representation of diverse populations in scientific research is imperative as a matter of social justice, economics, and science.”
— Oh S.S, et al. (2015). Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled. PLoS medicine. 12(12), e1001918.
“Fair and equitable access to cancer treatment in clinical research is imperative…as cancer injustice potentially risks scientific certainty, transparency, and availability. In fact, progress in cancer therapy cannot be fully realized unless innovations are accessible to all patients.”
— Zakout G.A. (2023). Practicing equitable principles in cancer clinical research: Has the EU got it right?. Journal of cancer policy, 37, 100435.
“There are many strategies “to increase enrollment of diverse populations, but they have produced mixed results. One strategy that has not been scaled up in a significant way is engaging community clinicians in research… access to clinical research is an essential component of providing equitable health care to our diverse population.”
— Woodcock J, Araojo R, Thompson T, Puckrein GA. Integrating Research Into Community Practice—Toward Diversity in Clinical Trials. New England Journal of Medicine. 2021;385(15):1351-1353
Course Testimonials
Interviews from Pilot
“I think the course was excellent. I was very impressed. I thought that everyone should take the course. … The content was excellent, and the way that it was provided was also very good. I found it very useful to learn information that I didn’t know before. And not only for PCPs, but medicine in general.”
“I liked how [the course] was engaging. … It was really good content to push me to be more hands-on in my patients’ cancer care process. So, I really liked it.”
“I think this topic is something that is needed. This is the first time I actually have had anyone bring it up, because cancer — it’s like a chronic disease now, ranked up with diabetes. … And so, I think this was a really good topic, and something just to get primary care providers thinking about.”
“I really liked the case scenarios where it gave you different options for how you would respond to a patient. I thought that gave really valuable feedback in how we phrase some of the topics that we bring up.”
“[The course] taught me a lot. … I feel like this entire program and access to additional education and information allowed me to just slow down and just take more time with the patient to explain further or to be there to answer different questions…that you may be bombarded with initially.”
Full Study Surveys
“This was an amazing course that really helped me in conversing in difficult conversations. It not only helped in cancer treatment discussions but in other discussions as well before sending patients to specialists.”
“I feel more prepared to support my patients with cancer and make them aware of [treatment] options.”
“[The course] brought to my attention the need for PCPs to address cancer treatment and continue to be actively involved in cancer care even when patient has started seeing heme/onc.”
Pilot Surveys
“As a PCP, I had no idea that I should and could play a role in the preparation of my patients prior to [going] to oncology.”
“[The course] provided great insight in the role that PCP play in clinical trials…”
“I really learned a lot and feel more prepared to discuss cancer care with my patients and supporting them through the process.”
“Interesting topic that I have not explicitly considered in the past. [The course] increased my general awareness to discuss cancer trials more openly.”